Stockreport

Delcath Systems Stock Gains on Positive CHEMOSAT Melanoma Data [Yahoo! Finance]

Delcath Systems, Inc.  (DCTH) 
US:NASDAQ Investor Relations: delcath.com/investors
PDF The study, conducted by researchers at the University of Tübingen, Germany, demonstrates that Delcath's CHEMOSAT Hepatic Delivery System significantly improves melanoma- [Read more]